Clinical Nuclear Medicine
https://libcat.nshealth.ca/en/permalink/provcat45206
Hojjat Ahmadzadehfar, Hans-Jürgen Biersack, Leonard M. Freeman, Lionel S. Zuckier, editors.
(Second edition)
--Cham:
Springer
, c2020.
- Available Online
- View e-Book
- Location
- Online
In the new edition of this very successful book, European and North American experts present the state of the art in diagnostic and therapeutic radionuclide procedures. The aim is to examine established and emerging clinical applications in detail, rather than to consider everything included in the comprehensive texts already available within the field. This “practical” approach ensures that the book will be a valuable guide for nuclear medicine physicians, technologists, students, and interest…
- Available Online
- View e-Book
- Responsibility
- Hojjat Ahmadzadehfar, Hans-Jürgen Biersack, Leonard M. Freeman, Lionel S. Zuckier, editors
- Edition
- Second edition
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2020
- Physical Description
- 1 online resource (ix, 1029 p.) : 494 illus., 280 illus. in color
- ISBN
- 9783030394578
- 9783030394554 (Print ed.)
- 9783030394561 (Print ed.)
- Subjects (MeSH)
- Diagnostic Imaging - methods
- Neoplasms - radiotherapy
- Nuclear Medicine
- Specialty
- Diagnostic Imaging
- Medical Oncology
- Radiotherapy
- Abstract
- In the new edition of this very successful book, European and North American experts present the state of the art in diagnostic and therapeutic radionuclide procedures. The aim is to examine established and emerging clinical applications in detail, rather than to consider everything included in the comprehensive texts already available within the field. This “practical” approach ensures that the book will be a valuable guide for nuclear medicine physicians, technologists, students, and interested clinicians alike. This edition of Clinical Nuclear Medicine has been extensively revised to take account of recent developments. The roles of SPECT/CT, PET/CT, and PET/MRI are clearly explained and illustrated, and the coverage extended to encompass, for example, novel PET tracers and therapeutic radionuclides, advanced techniques of brain imaging, and the development of theranostics. Readers will be fully persuaded of the ever-increasing value of nuclear medicine techniques in depicting physiology and function and complementing anatomic modalities such as CT, MRI, and ultrasound.
- Contents
- Part I. Basics -- 1. Physics, instrumentation, and radiation safety and regulations -- 2. Radiopharmaceutical sciences -- 3. Radiomics as applied in precision medicine -- Part II. Diagnostic Nuclear Medicine -- 4. Brain -- 5. Heart -- 6. Lung -- 7. Liver, spleen and biliary tree -- 8. The kidney -- 9. Gastrointestinal system -- 10. Musculoskeletal system -- 11. Application of lymphatic mapping and sentinel node biopsy in surgical oncology -- 12. Lymphoscintigraphy in the management of the lymphatic disorders -- 13. Neuroendocrine system -- 14. Thyroid and parathyroid imaging -- 15. Molecular Imaging of Inflammation and Infection -- 16. Imaging of atherosclerosis with 18F-FDG PET -- 17. PET/CT and PET/MRI Imaging, Normal Variations and Artifacts -- 18. PET in head and neck cancer -- 19. PET in gastrointestinal, pancreatic, and liver cancers -- 20. 18F-FDG-PET/CT in breast and gynecologic cancer -- 21. PET in lung cancer and mediastinal malignancies -- 22. Melanoma -- 23. PET in lymphoma -- 24. PET/CT in renal, bladder and testicular cancer -- 25. PSMA-ligand imaging in the diagnosis of prostate cancer -- 26. Miscellaneous -- 27. Radionuclide imaging of children -- Part III. Nuclear Medicine Therapy -- 28. Radioiodine therapy for benign thyroid disease -- 29. Differentiated thyroid cancer: Radioiodine therapy -- 30. Palliation of metastatic bone pain with radiolabeled phosphonates -- 31. Radionuclide therapy of bone metastases with radium-223 chloride in prostate cancer patients -- 32. Peptide receptor radionuclide therapy -- 33. Treatment of neuroendocrine tumors (neuroblastoma stage III or IV, metastatic pheochromocytoma, etc.) with 131I-mIBG -- 34. Radioimmunotherapy -- 35. Radioactive microspheres -- 36. Radioembolization -- 37. Assessment of tumor response with MRI and CT after radioembolization -- 38. Radioisotope therapy of malignant pleural and peritoneal effusions -- 39. Radiosynoviorthesis (radiation synovectomy) -- 40. Radioligand therapy in prostate cancer using PSMA-ligands.
- Format
- e-Book
- Location
- Online
